435 related articles for article (PubMed ID: 14623547)
1. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547
[TBL] [Abstract][Full Text] [Related]
2. Estrogen metabolites and breast cancer.
Santen RJ; Yue W; Wang JP
Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen versus aromatase inhibitors for breast cancer prevention.
Yue W; Wang JP; Li Y; Bocchinfuso WP; Korach KS; Devanesan PD; Rogan E; Cavalieri E; Santen RJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):925s-30s. PubMed ID: 15701888
[TBL] [Abstract][Full Text] [Related]
4. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors.
Devanesan P; Santen RJ; Bocchinfuso WP; Korach KS; Rogan EG; Cavalieri E
Carcinogenesis; 2001 Sep; 22(9):1573-6. PubMed ID: 11532882
[TBL] [Abstract][Full Text] [Related]
5. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
Santen R; Cavalieri E; Rogan E; Russo J; Guttenplan J; Ingle J; Yue W
Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
[TBL] [Abstract][Full Text] [Related]
6. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
7. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
Cavalieri E; Rogan E
Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
Yager JD
Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108
[TBL] [Abstract][Full Text] [Related]
9. The potential of aromatase inhibitors in breast cancer prevention.
Santen RJ; Yue W; Naftolin F; Mor G; Berstein L
Endocr Relat Cancer; 1999 Jun; 6(2):235-43. PubMed ID: 10731115
[TBL] [Abstract][Full Text] [Related]
10. Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Yue W; Berstein L
Endocr Relat Cancer; 2003 Jun; 10(2):111-30. PubMed ID: 12790774
[TBL] [Abstract][Full Text] [Related]
11. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
[TBL] [Abstract][Full Text] [Related]
13. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
14. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
15. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors.
Cavalieri EL; Kumar S; Todorovic R; Higginbotham S; Badawi AF; Rogan EG
Chem Res Toxicol; 2001 Aug; 14(8):1041-50. PubMed ID: 11511178
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
Russo J; Hasan Lareef M; Balogh G; Guo S; Russo IH
J Steroid Biochem Mol Biol; 2003 Oct; 87(1):1-25. PubMed ID: 14630087
[TBL] [Abstract][Full Text] [Related]
18. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.
Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG
J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757
[TBL] [Abstract][Full Text] [Related]
19. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms.
Yue W; Wang JP; Li Y; Fan P; Liu G; Zhang N; Conaway M; Wang H; Korach KS; Bocchinfuso W; Santen R
Int J Cancer; 2010 Oct; 127(8):1748-57. PubMed ID: 20104523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]